Return On Equity of Taysha Gene Therapies, Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Taysha Gene Therapies, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • Taysha Gene Therapies, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -67%, a 141% decline year-over-year.
  • Taysha Gene Therapies, Inc. annual Return On Equity for 2024 was -111%, a 107% decline from 2023.
  • Taysha Gene Therapies, Inc. annual Return On Equity for 2023 was 1701%.
  • Taysha Gene Therapies, Inc. annual Return On Equity for 2022 was -700%, a 547% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Taysha Gene Therapies, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -67% -39% -141% 01 Jul 2025 30 Sep 2025
Q2 2025 -80% +163% +67% 01 Apr 2025 30 Jun 2025
Q1 2025 -107% +1002% +90% 01 Jan 2025 31 Mar 2025
Q4 2024 -111% -1811% -107% 01 Oct 2024 31 Dec 2024
Q3 2024 -28% -884% -103% 01 Jul 2024 30 Sep 2024
Q2 2024 -243% -1468% -120% 01 Apr 2024 30 Jun 2024
Q1 2024 -1109% +716% +39% 01 Jan 2024 31 Mar 2024
Q4 2023 1701% +2401% 01 Oct 2023 31 Dec 2023
Q3 2023 856% +1196% 01 Jul 2023 30 Sep 2023
Q2 2023 1226% +1459% 01 Apr 2023 30 Jun 2023
Q1 2023 -1826% -1663% -1020% 01 Jan 2023 31 Mar 2023
Q4 2022 -700% -592% -547% 01 Oct 2022 31 Dec 2022
Q3 2022 -341% -270% -379% 01 Jul 2022 30 Sep 2022
Q2 2022 -233% -187% -409% 01 Apr 2022 30 Jun 2022
Q1 2022 -163% -115% -237% 01 Jan 2022 31 Mar 2022
Q4 2021 -108% -59% -119% 01 Oct 2021 31 Dec 2021
Q3 2021 -71% +1.7% +2.3% 01 Jul 2021 30 Sep 2021
Q2 2021 -46% -769% -106% 01 Apr 2021 30 Jun 2021
Q1 2021 -48% 01 Jan 2021 31 Mar 2021
Q4 2020 -49% 01 Oct 2020 31 Dec 2020
Q3 2020 -73% 01 Jul 2020 30 Sep 2020
Q2 2020 723% 01 Apr 2020 30 Jun 2020

Taysha Gene Therapies, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -111% -1811% -107% 01 Jan 2024 31 Dec 2024
2023 1701% +2401% 01 Jan 2023 31 Dec 2023
2022 -700% -592% -547% 01 Jan 2022 31 Dec 2022
2021 -108% -59% -119% 01 Jan 2021 31 Dec 2021
2020 -49% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.